Amlodipine And Olmesartan Medoxomil
Product Images NDC 45865-901

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Olmesartan Medoxomil (NDC 45865-901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (901)

Amlodipine and Olmesartan Medoxomil Tablets 10/40 mg packaging label from Medsource Pharmaceuticals, labeled as generic for Azor. The label includes dosage information, a warning about potential dizziness and pregnancy, manufacturer details (Teva Pharm. Ind. Ltd.), and an expiration and lot number area. The label instructs use as directed by a physician.*

FDA Label Image

Figure01 (Image 01)

A line graph showing the percentage of patients with systolic blood pressure (SBP) under 140 mmHg plotted against baseline SBP in mmHg. The graph compares four groups labeled Placebo, AML 10 mg, OM 40 mg, and Amlodipine and olmesartan medoxomil tablets 10 mg/40 mg, illustrating treatment efficacy relative to baseline SBP.*

FDA Label Image

Figure02 (Image 02)

A line graph depicting the percentage of diastolic blood pressure (DBP) less than 90 mmHg versus baseline DBP in mmHg. The graph compares four groups: placebo, Amlodipine 10 mg, Olmesartan Medoxomil 40 mg, and Amlodipine and Olmesartan Medoxomil tablets 10 mg/40 mg, with the combination showing the highest effectiveness in lowering DBP.*

FDA Label Image

Figure03 (Image 03)

A line graph comparing the percentage of subjects with systolic blood pressure (SBP) below 130 mmHg against baseline SBP (140-180 mmHg) for different treatments: placebo, OM40 mg, AML10 mg, and Amlodipine and Olmesartan Medoxomil tablets 10 mg/40 mg. The data lines show distinct trends for each treatment group.*

FDA Label Image

Figure04 (Image 04)

A line graph depicting the percentage of diastolic blood pressure (DBP) under 80 mmHg versus baseline DBP in mmHg. It compares placebo, AML 10 mg, OM 40 mg, and Amlodipine and olmesartan medoxomil tablets 10 mg/40 mg, showing better performance of the combination tablets in lowering DBP.*

FDA Label Image

Amlod Besy Chemical Structure (Image 05)

Chemical structure of the active ingredients in Amlodipine and Olmesartan Medoxomil, showing the molecular arrangement including characteristic rings, ester groups, and amine functionalities.*

FDA Label Image

Olmesartan Medoxomil Chemical Structure (Image 06)

Chemical structure of the active ingredient in Amlodipine and Olmesartan Medoxomil. The diagram shows the molecular arrangement with rings and functional groups representing the compound's complex chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.